Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Functional Capacity Screening Tool for Anemia in Cancer
NCT00540696Phase 2Completed
- Sponsor
- Amgen
- Start
- Sep 2001
- Primary completion
- Jun 2003
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 2 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started Sep 2001; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00540696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540696.